ENDRA Life Sciences Inc. (NDRA) vs Psychemedics Corporation (PMD)

ENDRA Life Sciences Inc. and Psychemedics Corporation are both Diagnostics & Research companies. Psychemedics Corporation is the larger, with a market value of $15.7M against $7.7M — 2.1× the size. ENDRA Life Sciences Inc. has the higher net margin (0.00% vs −9.45%) and the lower return on invested capital (−539.9% vs −31.4%). Across the 16 metrics below, Psychemedics Corporation leads on 10 and ENDRA Life Sciences Inc. on 6.

Valuation

Metric NDRA PMD Diagnostics & Research median
P/E n/m n/m 35.56
P/S 17.54 0.80 4.37
P/B 0.99 3.05 3.06
Price to free cash flow n/m 19.46 35.76
EV/EBITDA n/m 77.29 24.35
EV/Sales 2.22 0.74 5.51
Earnings yield (133.33%) (11.99%) (1.89%)
Free cash flow yield (124.95%) 5.14% (0.15%)

Profitability

Metric NDRA PMD Diagnostics & Research median
Gross margin 0.00% 36.07% 50.89%
Operating margin 0.00% (9.62%) (8.57%)
Net margin 0.00% (9.45%) (6.37%)
Free cash flow margin 0.00% 4.02% 0.00%
Return on equity (152.04%) (31.54%) (2.92%)
Return on assets (110.08%) (18.03%) (6.71%)
Return on invested capital (539.89%) (31.42%) 0.00%

Growth

Metric NDRA PMD Diagnostics & Research median
Revenue growth (TTM) — (10.92%) 7.69%
EPS growth (last fiscal year) 84.32% 55.56% 25.92%
Revenue growth, 5-year CAGR — (12.18%) 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NDRA PMD Diagnostics & Research median
Debt to equity 0.00 0.01 0.11
Current ratio 7.10 1.82 2.02
Net debt to EBITDA 0.14 (7.26) 0.70

Dividend

Metric NDRA PMD Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric NDRA PMD Diagnostics & Research median
Market cap 7.65m 15.70m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack